13 results on '"Coosemans W"'
Search Results
2. Current practice in antireflux and hiatal hernia surgery: exploration of the Belgian field
- Author
-
Depypere, L., primary, Van Veer, H., additional, Nafteux, P., additional, and Coosemans, W., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Diagnostic and Therapeutic Challenges in Treating an Esophago-Pleural Fistula Following Lung Transplantation
- Author
-
Vanluyten, C., primary, Vanstraelen, S., additional, Nafteux, P., additional, Van Slambrouck, J., additional, De Leyn, P., additional, Coosemans, W., additional, Decaluwé, H., additional, Van Veer, H., additional, Depypere, L., additional, Debaveye, Y., additional, De Vlieger, G., additional, Casaer, M., additional, Neyrinck, A., additional, Godinas, L., additional, Vos, R., additional, Verleden, G., additional, Bisschops, R., additional, Van Raemdonck, D., additional, and Ceulemans, L., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Recipient Outcome After Lung Transplantation from Older Donors (≥70 Years) Equals Younger Donors (< 70 Years): A Propensity-Matched Analysis
- Author
-
Vanluyten, C., primary, Vandervelde, C., additional, Vos, R., additional, Fieuws, S., additional, Van Slambrouck, J., additional, De Leyn, P., additional, Coosemans, W., additional, Nafteux, P., additional, Decaluwé, H., additional, Van Veer, H., additional, Depypere, L., additional, Denaux, K., additional, Desschans, B., additional, Ingels, C., additional, Verleden, S., additional, Godinas, L., additional, Dupont, L., additional, Verleden, G., additional, Neyrinck, A., additional, Van Raemdonck, D., additional, and Ceulemans, L., additional
- Published
- 2022
- Full Text
- View/download PDF
5. Impact of the introduction of an enhanced recovery pathway in esophageal cancer surgery: a cohort study and propensity score matching analysis.
- Author
-
Moons, J, Depypere, L, Lerut, T, Achterberg, T van, Coosemans, W, Veer, H Van, Mandeville, Y, and Nafteux, P
- Subjects
PROPENSITY score matching ,ESOPHAGEAL cancer ,COHORT analysis ,BLOOD transfusion reaction ,TREATMENT effectiveness ,ONCOLOGIC surgery ,NONINVASIVE ventilation - Abstract
Enhanced recovery pathways (ERP) have the potential to improve clinical outcomes. Aim of this study was to determine the impact of ERP on perioperative results as compared with traditional care (TC) after esophagectomy. In this study, two cohorts were compared. Cohort 1 represented 296 patients to whom TC was provided. Cohort 2 consisted of 200 unselected ERP patients. Primary endpoints were postoperative complications. Secondary endpoints were the length of stay and 30-day readmission rates. To confirm the possible impact of ERP, a propensity matched analysis (1:1) was conducted. A significant decrease in complications was found in ERP patients, especially for pneumonia and respiratory failure requiring reintubation (39% in TC and 14% in ERP; P <0.0001 and 17% vs. 12%; P <0.0001, respectively) and postoperative blood transfusion (26.7%–11%; P <0.0001). Furthermore, median length of stay was also significantly shorter: 13 days (interquartile range [IQR] 10–23) in TC compared with 10 days (IQR 8–14) in ERP patients (P <0.0001). The 30-day readmission rate (5.4% in TC and 9% in ERP; P =0.121) and in-hospital mortality rate (4.4% in TC and 2.5% in ERP; P =0.270) were not significantly affected. A propensity score matching confirmed a significant impact on pneumonia (P =0.0001), anastomotic leak (P =0.047), several infectious complications (P =0.01–0.034), blood transfusion (P =0.001), Comprehensive Complications Index (P =0.01), and length of stay (P =0.0001). We conclude that ERP for esophagectomy is associated with significantly fewer postoperative complications and blood transfusions, which results in a significant decrease of length of stay without affecting readmission and mortality rates. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Diagnosis and Management of Esophageal Fistulas After Lung Transplantation: A Case Series.
- Author
-
Vanstraelen S, Vos R, Dausy M, Van Slambrouck J, Vanluyten C, De Leyn P, Coosemans W, Decaluwé H, Van Veer H, Depypere L, Bisschops R, Demedts I, Casaer MP, Debaveye Y, De Vlieger G, Godinas L, Verleden G, Van Raemdonck D, Nafteux P, and Ceulemans LJ
- Abstract
Background: Lung transplantations are highly complex procedures, often conducted in frail patients. Through the addition of immunosuppressants, healing can be compromised, primarily leading to the development of bronchopleural fistulas. Although esophageal fistulas (EFs) after lung transplantation remain rare, they are associated with significant morbidity. We aimed to investigate the clinical presentation, diagnostic approaches, and treatment strategies of EF after lung transplantation., Methods: All patients who developed EF after lung transplantation at the University Hospitals Leuven between January 2019 and March 2022 were retrospectively reviewed and the clinical presentations, diagnostic approaches, and treatment strategies were summarized., Results: Among 212 lung transplantation patients, 5 patients (2.4%) developed EF. Three patients were male and median age was 39 y (range, 34-63). Intraoperative circulatory support was required in 3 patients, with 2 needing continued support postoperatively. Bipolar energy devices were consistently used for mediastinal hemostasis. All EFs were right-sided. Median time to diagnosis was 28 d (range, 12-48) and 80% of EFs presented as recurrent respiratory infections or empyema. Diagnosis was made through computed tomography (n = 3) or esophagogastroscopy (n = 2). Surgical repair with muscle flap covering achieved an 80% success rate. All patients achieved complete resolution, with only 1 patient experiencing a fatal outcome during a complicated EF-related recovery., Conclusion: Although EF after lung transplantation remains rare, vigilance is crucial, particularly in cases of right-sided intrathoracic infection. Moreover, caution must be exercised when applying thermal energy in the mediastinal area to prevent EF development and mitigate the risk of major morbidity. Timely diagnosis and surgical intervention can yield favorable outcomes., (Copyright © 2024 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
7. The Belsey Mark IV procedure in the era of minimally invasive antireflux surgery.
- Author
-
Ovaere S, Depypere L, Van Veer H, Moons J, Nafteux P, and Coosemans W
- Subjects
- Humans, Fundoplication methods, Retrospective Studies, Minimally Invasive Surgical Procedures, Recurrence, Treatment Outcome, Gastroesophageal Reflux surgery, Gastroesophageal Reflux complications, Hernia, Hiatal surgery, Hernia, Hiatal complications, Laparoscopy methods
- Abstract
Background: Different surgical techniques exist in the treatment of giant and complex hiatal hernia. The aim of this study was to identify the role of the Belsey Mark IV (BMIV) antireflux procedure in the era of minimally invasive techniques., Methods: A single-center, retrospective cohort study was conducted. All patients who underwent an elective BMIV procedure aged 18 years or older, during a 15-year period (January 1, 2002 until December 31, 2016), were included. Demographics, pre-, per- and postoperative data were analyzed. Three groups were compared. Group A: BMIV as first procedure-group B: BMIV as a second procedure (first redo intervention)-group C: patients who had two or more previous antireflux interventions., Results: A total of 216 patients were included for analysis (group A n = 127; group B n = 51; group C n = 38). Median follow-up in groups A, B and C was 28, 48 and 56 months, respectively. Patients in group A were older and had a higher American Society of Anesthesiologists score compared to groups B and C. There was zero mortality in all groups. The severe complication rate of 7.9% in group A was higher compared with the 2.9% in group B and 3.9% in group C. Long-term outcome showed true recurrence, defined as both radiographic recurrence as well as associated symptoms, in 9.5% of cases in group A, 24.5% in group B and 44.7% in group C., Conclusions: The BMIV procedure is a safe procedure with good results, moreover in the aging and comorbid patient with primary repair of a giant hiatal hernia., (© The Author(s) 2023. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
8. Primary Surgery Not Inferior to Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
- Author
-
Bouckaert A, Moons J, Lerut T, Coosemans W, Depypere L, Van Veer H, and Nafteux P
- Subjects
- Humans, Neoadjuvant Therapy adverse effects, Retrospective Studies, Neoplasm Staging, Chemoradiotherapy adverse effects, Postoperative Complications etiology, Esophagectomy methods, Esophageal Neoplasms, Adenocarcinoma therapy
- Abstract
Background: The current gold standard for treatment of locally advanced esophageal adenocarcinoma is neoadjuvant chemotherapy or chemoradiotherapy followed by surgery. The shift toward neoadjuvant chemoradiotherapy (nCRT) was driven by the Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) trial. This study reassessed, in daily practice, the presumed advantage of nCRT followed by surgery on long-term survival compared with primary surgery, in a group of all adenocarcinomas treated through a transthoracic approach with extensive 2-field lymphadenectomy., Methods: This retrospective cohort study with propensity score-matched analysis included all surgically treated patients between 2000 and 2018 with locally advanced adenocarcinoma (cT1/2 N+ or cT3/4 N0/+). For appropriate comparison, exclusion criteria of the CROSS trial were applied. Patients were matched on age, Charlson comorbidity score, clinical tumor length, and lymph node status. The primary end point was 5-year overall survival., Results: There were 473 eligible patients who underwent primary surgery (225 patients) or nCRT + surgery (248 patients). After propensity score-matched analysis, 149 matched cases were defined in each group for analysis. There was no significant difference after 5 years between the matched groups in median overall survival (32.5 and 35.0 months, P = .41) and median disease-free survival (14.3 and 13.5 months, P = .16). nCRT was associated with significantly more postoperative complications (mean Comprehensive Complication Index score: 21.0 vs 30.5, P < .0001) and longer mean stay in the hospital (14.0 vs 18.2 days, P = .05) and intensive care unit (11.7 vs 37.7 days, P = .05)., Conclusions: Our propensity score-matched results indicate that primary surgery, performed through transthoracic approach with extensive 2-field lymphadenectomy, can offer a comparable overall and disease-free survival after 5 years, with potentially fewer postoperative complications and shorter hospital and intensive care unit stay compared with nCRT followed by surgery., (Copyright © 2023 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
9. How to handle brain tumors after esophagectomy with curative intent: A single center 20-year experience.
- Author
-
Vanstraelen S, Depypere L, Moons J, Mandeville Y, Van Veer H, Lerut T, Coosemans W, and Nafteux P
- Subjects
- Humans, Esophagectomy, Combined Modality Therapy, Retrospective Studies, Survival Rate, Esophageal Neoplasms pathology, Brain Neoplasms surgery
- Abstract
Background: Brain metastases after esophagectomy are rare. Moreover, a diagnostic uncertainty remains as pathology is rarely obtained and radiological features can show similarities to primary brain tumors. Our aim was to demonstrate the diagnostic uncertainty and identify risk factors associated with brain tumors (BT) after esophagectomy with curative intent., Methods: All patients who underwent an esophagectomy with curative intent from 2000 to 2019 were reviewed. Diagnostics and characteristics of BT were analyzed. Multivariable logistic and cox regression were performed to determine factors associated with development of BT and survival, respectively., Results: In total, 2131 patients underwent esophagectomy with curative intent, of which 72 patients (3.4%) developed BT. Pathological diagnosis was obtained in 26 patients (1.2%), of which 2 patients were diagnosed with glioblastoma. On multivariate analysis, radiotherapy (OR, 7.71; 95%CI: 2.66-22.34, p < 0.001) was associated with an increased risk of BT and early-stage tumors (OR, 0.29; 95%CI: 0.10-0.90, p = 0.004) with a decreased risk of BT. Median overall survival was 7.4 months (95%CI: 4.80-9.96). BT treated with curative intent (surgery or stereotactic radiation) had a significantly better median overall survival (16 months; 95%CI: 11.3-20.7) compared to those without (3.7 months; 95%CI: 0.9-6.6, p < 0.001) CONCLUSIONS: Advanced stage tumors and radiotherapy seem related to the development of brain tumors after esophagectomy with curative intent. However, an important diagnostic uncertainty remains in these patients as pathological diagnosis is only obtained in a minority of cases. Tissue confirmation can be useful to inform a patient-tailored multimodality treatment strategy in select patient., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
10. Real-life introduction of powered circular stapler for esophagogastric anastomosis: cohort and propensity matched score study.
- Author
-
Vanstraelen S, Coosemans W, Depypere L, Mandeville Y, Moons J, Van Veer H, and Nafteux P
- Subjects
- Humans, Retrospective Studies, Quality of Life, Surgical Staplers adverse effects, Anastomosis, Surgical adverse effects, Anastomosis, Surgical methods, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Complications prevention & control, Esophagectomy adverse effects, Esophagectomy methods, Propensity Score, Anastomotic Leak etiology, Anastomotic Leak prevention & control, Anastomotic Leak surgery, Esophageal Neoplasms surgery, Esophageal Neoplasms complications
- Abstract
Anastomotic leakage after esophagectomy is one of the most feared complications, which results in increased morbidity and mortality. Our aim was to evaluate the impact of a powered circular stapler on complications after esophagectomy with intrathoracic anastomosis for esophageal cancer. Between May 2019 and July 2021, all consecutive oesophagectomies for cancer with intrathoracic anastomosis in a high-volume center were included in this retrospective study. Surgeons were free to choose either a manual or a powered circular stapler. Preoperative characteristics and postoperative complications were recorded in a prospective database, according to EsoData. Propensity score matching (age, body mass index, Eastern cooperative oncology group (ECOG) performance and neoadjuvant therapy) was conducted to reduce potential confounding. We included 128 patients. Powered and manual circular staplers were used in 62 and 66 patients, respectively. Fewer anastomotic leakages were observed with the powered stapler group (OR = 7.3 (95%CI: 1.58-33.7); [3.2% (n = 2) vs 19.7% (n = 13), respectively; p = 0.004]). After propensity score matching, this remained statistically significant (OR = 8.5 (95%CI: 1.80-40.1); [4.1% (n = 2) vs 20.4% (n = 10), respectively; p = 0.013]). Additionally, anastomotic diameter was significantly higher with the powered stapler (median: 29 mm (63.3%) vs 25 mm (57.1%), respectively; p < 0.0001). There was no significant difference in comprehensive complication index (p = 0.146). A decreased mean length of stay was observed in the powered stapler group (11.1 vs 18.7 days respectively; p = 0.022). Postoperative anastomotic leakage after esophageal resection was significantly reduced after the introduction of the powered circular stapler, consequently resulting in a reduced length of stay. Further evaluation on long-term strictures and quality of life are warranted to support these results., (© The Author(s) 2022. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus.)
- Published
- 2023
- Full Text
- View/download PDF
11. Impact of anastomosis time during lung transplantation on primary graft dysfunction.
- Author
-
Vandervelde CM, Vos R, Vanluyten C, Fieuws S, Verleden SE, Van Slambrouck J, De Leyn P, Coosemans W, Nafteux P, Decaluwé H, Van Veer H, Depypere L, Dauwe DF, De Troy E, Ingels CM, Neyrinck AP, Jochmans I, Vanaudenaerde BM, Godinas L, Verleden GM, Van Raemdonck DE, and Ceulemans LJ
- Subjects
- Anastomosis, Surgical adverse effects, Cohort Studies, Humans, Retrospective Studies, Risk Factors, Lung Transplantation adverse effects, Primary Graft Dysfunction etiology
- Abstract
Primary graft dysfunction (PGD) is a major obstacle after lung transplantation (LTx), associated with increased early morbidity and mortality. Studies in liver and kidney transplantation revealed prolonged anastomosis time (AT) as an independent risk factor for impaired short- and long-term outcomes. We investigated if AT during LTx is a risk factor for PGD. In this retrospective single-center cohort study, we included all first double lung transplantations between 2008 and 2016. The association of AT with any PGD grade 3 (PGD3) within the first 72 h post-transplant was analyzed by univariable and multivariable logistic regression analysis. Data on AT and PGD was available for 427 patients of which 130 (30.2%) developed PGD3. AT was independently associated with the development of any PGD3 ≤72 h in uni- (odds ratio [OR] per 10 min 1.293, 95% confidence interval [CI 1.136-1.471], p < .0001) and multivariable (OR 1.205, 95% CI [1.022-1.421], p = .03) logistic regression analysis. There was no evidence that the relation between AT and PGD3 differed between lung recipients from donation after brain death versus donation after circulatory death donors. This study identified AT as an independent risk factor for the development of PGD3 post-LTx. We suggest that the implantation time should be kept short and the lung cooled to decrease PGD-related morbidity and mortality post-LTx., (© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2022
- Full Text
- View/download PDF
12. Preserving the eponym: Klinkenbergh technique for bronchial stump suturing.
- Author
-
Prisciandaro E, Decaluwé H, De Leyn P, Coosemans W, Nafteux P, Van Veer H, Depypere L, Lerut T, Van Raemdonck D, and Ceulemans LJ
- Subjects
- Bronchi surgery, Eponyms, Humans, Pneumonectomy, Postoperative Complications, Sutures, Bronchial Fistula surgery, Lung Neoplasms surgery
- Abstract
The technique for bronchial stump suturing following lung resection which is currently applied in the Department of Thoracic Surgery at the University Hospitals Leuven, Belgium owes its name to the Dutch surgeon Dr. Klinkenbergh (1891-1985). A true pioneer of cardiothoracic surgery in Europe, Dr. Klinkenbergh dedicated himself to the surgical treatment of pulmonary tuberculosis. His work was praised by his peers for his precision and the reasoning behind every gesture. The Klinkenbergh technique consists in performing two running sutures which cross each other 'in the same manner as the laces of a shoe' to close the bronchus, limiting the occurrence of broncho-pleural fistulas. In our experience with more than 100 patients in the last 5 years (2016-2020) who underwent open pneumonectomy for benign or malignant disease, less than 2% developed post-operative broncho-pleural fistulas.
- Published
- 2021
- Full Text
- View/download PDF
13. Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
- Author
-
Depypere L, De Hertogh G, Moons J, Provoost AL, Lerut T, Sagaert X, Coosemans W, Van Veer H, and Nafteux P
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma secondary, Aged, Belgium epidemiology, Biopsy, Fine-Needle methods, Chemoradiotherapy, Adjuvant methods, Endoscopy, Gastrointestinal methods, Endosonography, Esophageal Neoplasms diagnosis, Esophageal Neoplasms mortality, Esophageal Neoplasms secondary, Female, Follow-Up Studies, Humans, Lymph Nodes drug effects, Lymph Nodes radiation effects, Lymphatic Metastasis, Male, Middle Aged, Retrospective Studies, Survival Rate trends, Adenocarcinoma therapy, Esophageal Neoplasms therapy, Esophagectomy methods, Lymph Nodes pathology, Neoplasm Staging
- Abstract
Background: Tumor response and lymph node involvement are the most important prognosticators in resected patients with esophageal adenocarcinoma after neoadjuvant chemoradiotherapy (nCRT). We hypothesize that lymph node response (LNR) is also a valuable prognosticator in these patients, potentially revealing the added effect of nCRT., Methods: Hematoxylin and eosin slides of 193 esophageal adenocarcinoma patients with clinical suspicion of lymph node involvement (cN+) and treated with nCRT between 2008 and 2015 were assessed. Lymph nodes containing viable tumor cells were considered ypN+, and those negative for viable tumor were ypN0. LNR was also described according to an earlier defined method. Three groups were obtained: ypN0/LNR-, ypN0/LNR+, and ypN+. They were compared with 188 cN+ patients being pN0 (n = 45) or pN+ (n = 143) after upfront esophageal resection., Results: Forty-four patients were ypN0/LNR-, 55 were ypN0/LNR+, and 94 were ypN+. Median overall survival was 96.4, 31.2, and 20.6 months, respectively, and was significantly different between ypN0/LNR- and ypN0/LNR+ groups (P = .020). Survival was comparable between ypN0/LNR- and pN0 (104.2 months) groups (P = .519) and between ypN+ and pN+ (21.6 months) groups (P = .966). In ypN0 patients, risk of death in LNR+ patients was tripled compared with LNR- patients., Conclusions: In cN+ esophageal adenocarcinoma patients treated with nCRT with postoperative final pathology being ypN0, median overall survival is tripled when no signs of LNR were found and comparable to cN+/pN0 upfront esophagectomy patients, suggesting that 23% of patients treated with nCRT were in fact true N0 and overtreated by nCRT. ypN+ patients have no survival benefit compared with pN+ patients., (Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.